The MLL gene, located at 11q23, is frequently rearranged in acute leukaemia as either chimaeric fusion genes or partial tandem duplications. We report a series of 12 acute leukaemia cases with apparent amplification of the MLL gene ascertained using fluorescence in situ hybridisation (FISH). Seven cases showed intrachromosomal amplification of MLL, four cases showed extrachromosomal amplification as double minute chromosomes (dmin) and one case had separate subclones with dmin and homogenously staining region (hsr). Southern blot analysis of the MLL gene showed MLL gene rearrangement in three of the 10 successful cases. These cases do not naturally fall into either of the two recognised categories of MLL rearrangement and may represent a third variety of MLL gene abnormalities.
Introduction
Cytogenetic abnormalities at chromosome band 11q23 are seen in a wide variety of leukaemias. At the molecular level, these abnormalities usually involve the MLL gene.
The most common type of MLL gene abnormality is the reciprocal translocation. Over 25 partner sites for such rearrangements have been identified and the molecular basis of many has been elucidated. 1, 2 MLL translocations are seen in both acute myeloid and acute lymphoblastic leukaemia, are strongly associated with infant leukaemia and most have been associated with a poor clinical outlook. 3, 4 Therefore the accurate detection of such abnormalities can be of clinical value in assigning individual cases to risk categories at presentation.
A different mode of rearrangement of the MLL gene is internal partial tandem duplication (PTD) or 'self fusion' which has been reported in approximately 10% of acute myeloid leukaemia (AML) cases with a normal karyotype 5 and in the majority of cases of trisomy 11 as a sole abnormality in AML. 6 MLL partial tandem duplications have been associated with decreased duration of complete remission. 5 Gene amplification traditionally manifests cytogenetically in one of two ways, either intrachromosomally as homogeneously staining regions (hsr) or extrachromosomally as double minute chromosomes (dmin). Fluorescence in situ hybridisation (FISH) allows identification of genes included in the amplified regions. Gene amplification is a common abnormality in a wide range of tumours but is relatively rare in acute leukaemia. In AML, approximately 1% of cases demonstrate dmin on cytogenetic analysis. 7 While the gene most com- monly present in the amplicon is MYC (normally located at 8q24), 8 there have also been reports of amplification of MLL. [9] [10] [11] [12] In a national collaborative study, we collected 12 cases demonstrating MLL amplification based upon FISH studies using the Oncor MLL probe. We compared their karyotypic and clinical features and investigated the integrity of the MLL gene using Southern blot analysis.
Materials and methods
Cases demonstrating MLL amplification were submitted from five member cytogenetic laboratories of the United Kingdom Cancer Cytogenetics Group (UKCCG). Case 2 was submitted from Dijon, France (previously reported by Harrison et al 13 ). These cases were ascertained from routine use of MLL FISH using the Oncor MLL DNA probe (Oncor, Gaithersburg, MD, USA) which was undertaken where conventional G-banding analysis had revealed either a possible hsr at 11q23, or the presence of dmin. FISH was performed on diagnostic bone marrow preparations using standard methods. G-banded karyotypes were described according to the International System for Human Cytogenetic Nomenclature (ISCN 1995).
14 In case 7, G-banding studies failed and MLL FISH was performed on interphases to rule out the presence of an MLL rearrangement. The criterion for selection of patients was the presence of multiple MLL signals. MLL amplification was defined as the presence of a clone of cells with four or more discrete signals or a region of fluorescence representing multiple contiguous signals. (Multiple signals can also result from duplications of 11q23 translocation products; such cases were not considered to represent amplification and were excluded from this study.)
DNA extraction from fixed cell suspension was attempted in all cases. Southern blot analysis was performed using the 0.74-kb MLL cDNA probe which detects all rearrangements within the MLL breakpoint cluster region (exons 5-11). 15 The 0.74-kb probe was hybridised to BamHI digested total genomic DNA using standard Southern blotting protocols. Southern blot detection of an MLL gene abnormality was defined as the presence of a rearranged band(s) in addition to the normal 8.3-kb germline band. Table 1 summarises the karyotype, clinical, haematological and molecular data on the 12 cases in this study. (7)del (7)(q2?q3?)t(7;17)(q36;q23ෂ24),der(11)?qdp (11) 
Results

Clinical details
Eleven of the 12 cases presented are AML. One case was FAB type M5, whereas five were AML M1 (seven were either M0 or M1). One case (case 4) was therapy-related AML (t-AML).
One case was common acute lymphoblastic leukaemia (c-ALL) (case 7). Nine of the 11 AML cases were male. The ages of the AML cases ranged from 48 to 78 years, with a mean age of 67 years. The single ALL case was a male aged 7 years.
Karyotype G-banded analysis was successful in 11 of the 12 cases. Case 7 failed to produce any metaphases and MLL amplification was demonstrated by interphase FISH alone. Of the remaining 11 cases, all had abnormal karyotypes of which 10 were complex (defined by the presence of a clone with at least five unrelated cytogenetic abnormalities, after Grimwade et al 16 ).
The overall mean number of unrelated cytogenetic abnormalities in the karyotyped cases was 8.1.
MLL FISH
Seven of the 12 cases showed intrachromosomal amplification of MLL based on location of FISH signal (cases 1-7). No metaphases were available for case 7, although interphase FISH showed MLL signal localised in a very defined region ( Figure  1 
Southern blot analysis
Ten of the 12 cases generated sufficient DNA for Southern blot analysis. Of these 10 cases, seven showed only a germline MLL band and three (cases 1, 5 and 9) showed one or more additional rearranged band(s) (see Figure 1 , images 1, 5 and 9).
Survival
Only two of the 12 cases were still alive at the time of writing. Overall median survival was 1 month. Median survival of the 11 AML cases was also 1 month.
Discussion
Amplification of the MLL gene is a documented phenomenon in AML. [9] [10] [11] [12] A brief summary of the 10 previously reported cases of MLL amplification is shown in 19, 20 and one in a myeloid leukaemia derived cell line. 21 Although not originally reported as 'MLL amplification', all three could be classified as such using the criteria of our study.
The majority of these studies have cited copy numbers of MLL, presumably based upon counting of FISH signals without taking into account size or intensity of those signals. We felt that in most of our cases it would be impossible to accurately quantify the number of signals and consequently did not attempt to do so.
The current study represents the largest collection to date of acute leukaemia cases which demonstrate the phenomenon of MLL gene amplification. We found 12 cases of acute leukaemia which met our definition of MLL amplification based upon FISH analysis.
Our experience of these cases using FISH suggests that gene amplification may take other forms than the traditional hsr and dmin. For instance, cases 1, 3 and 6 clearly demonstrate intrachromosomal MLL amplification on FISH (Figure 1 , images 1, 3 and 6) but not an hsr on G-banding. Dmin are a rare finding in acute leukaemia. Fourteen cases of dmin in acute leukaemia have been analysed using molecular techniques. [22] [23] [24] Of these, 10 were shown to contain MYC sequences (normally located at 8q24), three showed amplification of MLL sequences 10, 12 and one showed amplification of various genes on 11q23-24. 22 Our study contributes a further five acute leukaemias with MLL sequences present on dmin. Case 12 demonstrates one abnormal clone with MLL positive dmin whilst another clone shows no dmin, but a MLL positive hsr. The simultaneous occurrence of dmin and hsr in different cells of a single malignancy appears to represent the re-integration of dmin into a chromosome to form a hsr. This has only been reported previously in tumours and tumourderived cell lines. 25, 26 This is the first report of such a phenomenon in acute leukaemia.
The patients in this series were predominantly males with de novo AML, complex karyotype and mean age of 67 years. The median survival of only 1 month is entirely consistent with the age, clinical and karyotypic features of these patients, 27 hence it is not possible to speculate about the prognostic significance of MLL amplification in these patients.
The most common phenotype of AML cases with typical MLL translocations is AML M5. 28 It is clear from our series and published reports that this FAB association does not hold true for most cases of MLL amplification.
Several of the previous reports of MLL amplification have suggested a significant proportion of MLL amplification cases to be therapy-related leukaemias. 11, 19, 20 In contrast, this study contains only one such case (case 4).
In this study the aim was to investigate the relationship of MLL amplification to molecular MLL rearrangement. The
Figure 1
Representative MLL FISH images from each of the cases in this collection. With the exception of cases 8 and 9, all images show MLL probe in red with a blue counterstain. Image 8 has a red counterstain with MLL probe appearing yellow and image 9 has MLL appearing green. Cases with a molecular MLL rearrangement have inset image of Southern blot analysis (images 1, 5 and 8) with rearranged band(s) arrowed. Images 12a and 12b show separate clones of case 12 with MLL signal present on dmin and hsr, respectively. (9)t(Y;9)(q1?2;p22)t(9;19)(q1?2;p12),del(5)(q1?2q3?4),−7,−9,dic(11)t(9;11;19),der(14;21)(q10;q10)del (14) cell line (11) (7)x2,der(7)t(7;15)del (7)del (15),dup (8) ,+der (8)trp (8) Figure 1 , images 1, 5 and 8). However it is possible that case 8 may represent a false positive result as the band sizes conform to the pseudo-rearrangement of MLL reported by Stanulla et al. 29 Our limited data suggest that rearrangement of the MLL gene is not commonly seen in cases of amplification.
Common routine use of MLL FISH could be a contributing factor to detection of this apparent phenomenon of MLL amplification. All cases here were ascertained using MLL FISH, which is now widely used in diagnostic cytogenetics centres. It is difficult to establish whether MLL amplification is merely an epiphenomenon of genetic instability or plays a role in leukaemia progression. It is possible that similar widespread use of other FISH probes, particularly in cases with complex karyotypes, might highlight examples of other amplified genes. It was not possible within this study to estimate the incidence of MLL amplification -to do this would require that MLL FISH was carried out on all cases of acute leukaemia. However, this phenomenon is clearly rare; the 13 previously reported cases plus the 12 in our study represent the total reports in the world literature.
The FISH approach used in this study gives few insights into the detailed structure of the amplicons in these cases. In particular, the possibility of other genes being co-amplified with MLL cannot be excluded. We note that three cases have been reported of AML with amplification of the 11q23-qter region based on comparative genomic hybridisation (CGH) and Southern blotting studies. [30] [31] [32] [33] In two of these three cases the MLL gene was not involved, whereas other genes from 11q23 were amplified (eg ETS1). It is possible that MLL is merely a linked passenger to another -perhaps more biologically significant -gene in some or all of these amplification events. On the other hand, it is difficult to resolve this possibility with the fact that MLL is one of the most common genetic targets in leukaemia.
In summary, this study shows that MLL amplification takes more than one cytogenetic form, ie not always hsr or dmin. MLL gene rearrangement does not appear to be a consistent feature and these cases do not show the same clinico-pathological features as typical MLL/11q23 translocations.
